In this issue
-
s Sponsored
What is the single most important message for policymakers?
Addressing AMR-restrained patients’ access and market failure requires a fundamental shift away from volume-based toward value-contribution valuation healthcare policies. Why is antimicrobial resistance (AMR) becoming one of the greatest threats to patients’ lives and to our modern medicine? Worldwide, there are 4.95 million AMR-associated deaths annually. They’re projected to exceed 10 million deaths yearly by...
-
s Sponsored
Antimicrobial resistance threatens treatment progress and the lives of cancer patients
A cancer advocacy group warns that data relating to antimicrobial infections (AMI) in cancer patients is being under-recorded in hospitals across Europe. Cancer Patients Europe (CPE) believes the risk posed by antimicrobial resistance (AMR) in cancer care is being overlooked and that the cause of death in cancer sufferers often fails to reflect the fact...
-
s Sponsored
Novel antibiotics are failing to reach patients: here’s why and what needs to change
A leading expert voices highly cautious optimism over the very few steps taken today that could help tackle the threat to patients’ lives and their medical care from antimicrobial resistance (AMR). With AMR contributing to millions of deaths and costing the global economy billions of dollars, Dr Najy Alsayed, Head of Infectious Diseases in Menarini,...
Global Cause